Patients with early pre-dialysis care presented a higher prevalence of comorbidities, lower levels of creatinine, phosphorus, and glucose with a significantly better control of hemoglobin and potassium serum levels. There was no impact of pre-dialysis care on peritonitis rates (hazard ratio (HR) 0.88; 95% CI 0.77-1.01) and technique survival (HR 1.12; 95% CI 0.92-1.36). Patient survival (HR 1.20; 95% CI 1.03-1.41) was better in the early pre-dialysis care group. Conclusion: Earlier pre-dialysis care was associated with improved patient survival, but did not influence time to the first peritonitis nor technique survival in this national PD cohort.
grams. Therefore, CKD disease-management programs should be developed and are of an utmost necessity [1] . This is particularly evident in many countries, where there is increasing access to RRT and no structured CKD care programs [2] .
CKD patients in hemodialysis (HD) and peritoneal dialysis (PD) are at higher risks of hospitalization and mortality [3] . In PD, understanding factors associated with high mortality and technique failure (particularly due to peritonitis) rates is a major challenge in the management of this population group [2, 3] . Adequate CKD management is associated with better patient survival in previous reports in the HD population [4, 5] . In addition, previous studies described that patients with adequate pre-dialytic care presented better control of anemia, nutritional status and cardiovascular (CV) condition [5, 6] . Interestingly, structured pre-dialysis care was associated with an increase in patient choice of PD and increase in the penetration of PD use [7] [8] [9] .
Studies looking broadly at the impact of pre-dialysis care on outcomes (patient and technique survival), particularly in centers with fast expansion of access to dialysis treatment are scarce and limited to HD, except for one single-center study from China [10] . Finally, an analysis on the impact of pre-dialysis care on patient outcomes adjusted for laboratory, nutritional and hydroelectrolytic imbalance has not been performed until the present. In this study, we aimed at analyzing the impact of pre-dialysis care on PD patients and technique outcomes in a Brazilian national representative cohort.
Methods

Patient Population
This is a prospective study based on the BRAZPD II cohort, including data from 122 dialysis centers of all regions from Brazil. The number of prevalent patients in each year corresponded to 65-70% of all PD patients in the country in that same year. Data collection included socio-demographic data and comorbid conditions at the baseline and various prescription, clinical and laboratory data, collected periodically depending on the variable. The main outcomes captured in the study were dropped out from PD and total and cause-specific mortality [11] .
For this study, we identified all adult patients starting PD between 2004 and 2011, and within that subset, all those with valid data about pre-dialysis care were included. Patients with previous RRT were excluded ( fig. 1 ). All patients provided written consent, which was approved by the Brazilian Ethical Committee number 448. For the comparative analysis, patients were stratified into 2 groups according to the time of pre-dialysis care: patients who had at least 90 days of pre-dialysis follow-up with a nephrology team (early pre-dialysis care) and patients who did not have or had less than 90 days follow-up with a nephrology team (late pre-dialysis care). Center experience was measured in patient-year, for example, the follow-up time of all patients from a certain center was summed up and the result divided by the number of years that the center participated in the study.
Data Collection
Data were collected using PDNet software that contained a form with important and relevant information for the design of the study. The pre-dialysis questionnaire was included in the medical form, providing information that characterized the pre-dialysis nephrological care (i.e. whether the patient received pre-dialysis care, time that received care, if received orientation regarding dialysis method options, how the treatment was indicated, by whom was the patient referred to a nephrology specialist and if the specialist had vascular access). The pre-dialysis medical questionnaire, and 2 questions '(1) Did the patient receive pre-dialysis care? and (2) For how long was the pre-dialytic care done?' were used to define the groups for the analysis.
Clinical Outcomes
Death, recovery of renal function, renal transplantation, permanent transfer to HD, and lost to follow-up were factors based on which dropouts were defined. In the analysis of time to first 106 peritonitis episode, those who dropped out of the study before experiencing any peritonitis episode and those were still alive at the end of follow-up without any peritonitis episode were censored. In the analysis of technique survival, the event of interest was defined as permanent switch to HD because of any valid cause. Patients who died, those who were still alive at the end of the follow-up, and those who received a renal transplantation were censored. For the analysis of patient survival, the event of interest was death by any cause, and all patients who dropped out of the study for any reason or those still alive at the end of the study were censored.
Statistical Analysis
Continuous variables were expressed as mean ± SD or median and range, while categorical variables (e.g. gender, race, primary renal disease, presence of comorbid conditions, initial therapy, current PD modality, etc.) were expressed as frequencies or percentages. The traditional Cox proportional hazards model was used for clinical outcomes, and to be included in the multivariate model, a covariate should have had a p value <0.20 in the univariate analysis. Cox proportional hazard models were estimated using SPSS 20.0. Assumptions for proportional hazards were checked with residual plots. Statistical significance was set at the level of p < 0.05. Two models were constructed to analyze the independent effect of pre-dialysis care on patient outcome: the first model analyzed only demographic and clinical variables, while the second model also included biochemical variables (hemoglobin, potassium and phosphorus).
Results
Patient Characteristics
The flowchart of patients selected for the analysis is summarized in figure 1 . Among the 4,107 incident patients on PD, 2,107 patients presented early and 2,000 patients presented late for pre-dialysis care. Clinical and demographical characteristics of the study population are presented in table 1 . In general, patients from the early pre-dialysis care group present lower educational levels (61.9% with less than 4 years of formal education vs. 71.0%) and exhibited a significant higher prevalence of comorbidities: coronary (23.4 vs. 19.5), diabetes (50.0 vs. 39.8%), hypertension (75.6 vs. 64.3%), left ventricular hypertrophy (30.1 vs. 20.1%), peripheral artery diseases (19.9 vs. 16.2%), and overweight (45.8% with a body mass index (BMI) >25 vs. 40.9). Finally, patients with early predialysis care tended to have lower average levels of creatinine, phosphorus, glucose and higher levels of hemoglobin at the first 3 months of PD.
The dynamics of biochemical variables analyzed throughout the subsequent quarters of the first year on PD treatment showed that although phosphorus control were not significantly different between the groups, patients from the early pre-dialysis care presented a significantly better control of hemoglobin and potassium serum levels ( table 1 and fig. 2 ).
Time to First Peritonitis Episode
The percentage of patients without pre-dialysis care who presented at least one peritonitis episode was 12.8 (n = 257), while in the group with pre-dialysis care the percentage was 15.6 (n = 329). The time to the first peritonitis episode was similar between groups even after adjustment for covariates (hazard ratio (HR) 0.88; 95% CI 0.77-1.01). There were only 2 independent predictors for the primary event of interest: cancer (HR 1.48; 95% CI 1.07-2.02) and education <4 years (HR 1.17; 95% CI 1.01-1.35). The multivariate model comprised the following variables: dialysis vintage, BMI, cancer, center experience, education level and region of the country. Again, the inclusion of biochemical variables did not alter the effect of pre-dialysis care in the outcome.
Technique Failure
Early pre-dialysis care was not significantly associated with technique failure (HR 1.12; 95% CI 0.92-1.36). In absolute numbers, there were 242 (11.5%) dropouts in the group with pre-dialysis care and 199 (9.9%) in those without pre-dialysis care. On the basis of the criteria described above, we included the following covariates in the univariate analysis: cancer, coronary artery disease, center experience, diabetes, distance to the PD center, gender, PD modality, region of the country and peripheral artery disease. The covariates that were significantly associated with technique failure in the multivariate analysis were center experience (per 1 patient-year of increase: HR 0.99; 95% CI 0.98-0.99), female gender (HR 0.79; 95% CI 0.65-0.96) and continuous ambulatory PD (CAPD) (HR 0.82; 95% CI 0.67-0.99).
Patient Survival
The main cause of death was CV disease for the late pre-dialysis group with 142 events (40.9%), followed by sepsis not related to PD with 101 events (29.1%), while in the early pre-dialysis group it was the inverse: sepsis with 154 events (40.8%) and CV disease with 127 events (33.7%). The univariate analysis identified age >65 years, BMI, cancer, coronary artery disease, peripheral artery disease, center experience, diabetes, education <4 years, hypertension, PD modality and race as significantly associated with the primary event of interest. Late pre-dialysis care (HR 1.20; 95% CI 1.03-1.41), age >65 years (HR 2.97; 95% CI 2.52-3.50), BMI <18. Table 2 summarizes the effect of pre-dialysis care for all events studied, while figure 3 depicts the curves for time to event. 
Discussion
To the best of our knowledge this is the first large cohort study to evaluate the impact of pre-dialysis care on PD patient outcomes, indicating that early pre-dialysis care is independently associated with better survival on PD, even after adjusting for risk factors including biochemical variables. Moreover, pre-dialysis care was associated with an attenuation of CKD progression [8] , better clinical outcome in HD patients and greater frequency of PD as the first choice in the RRT [12] .
Early and late pre-dialysis groups differed significantly in some clinical and demographic characteristics ( table 1 ). Not surprisingly, patients from the late pre-dialysis group had a lower education level, a lower prevalence of comorbidities and uncontrolled biochemical variables, including higher potassium and lower hemoglobin levels. This is probably due to earlier referral of these patients having comorbidities and are then assisted, different from the asymptomatic, many of whom do not know who have CKD and then are referred later to nephrologists. These negative effects of the lack of pre-dialysis care on biochemical parameters have already been described in the late nineties [13] and may play a significant role in patient outcomes. Our study is the first attempt to analyze the possible impact of pre-dialysis care in technique survival and in the time to first peritonitis episode in PD patients. We found no association between pre-dialysis care and those outcomes. The lack of association between pre-dialysis care with technique failure could be explained by the fact that previously identified risk factors for this outcome, such as membrane profile, dialysis vintage, sex, literacy, diabetes, glucose exposure, and anuria, cannot be modified by a more appropriate pre-dialysis care [11, 14, 15] . The same holds true for the time-to-first-peritonitis episode, since its most commonly described risk factors are diabetes, education, family income, region (e.g. rural or not), home distance to the PD center, age and race. More importantly, adequate dialysis care, including patient selection and training may be enough to offer patients adequate technique survival and risk of peritonitis, regardless of pre-dialysis care. Nevertheless, differences related to the pattern of training addressed to patients with and without pre-dialysis care may impact the time to first peritonitis outcome [16] .
Importantly, we observed that early pre-dialysis care significantly affected patient survival even after adjust- 110 ments for several and important covariates. One of the possible reasons to explain such differences in mortality rates is the worst control of biochemical/metabolic parameters in patients not receiving pre-dialysis care. In fact, a hemoglobin level <10 g/dl, a potassium level either <3.5 or >5.5 mEq/l and a phosphorus level <3.5 mg/dl at baseline were significantly associated with mortality in the univariate analysis. Nevertheless, the inclusion of biochemical covariates at baseline in the model does not alter the negative impact of late pre-dialysis care. This may be partially explained because that difference initially observed at baseline disappears along the first year of treatment ( fig. 2 ) . Another possibility to explain these differences is changes in residual renal function (RRF), which are not captured in our study. However, since all patients were undergoing dialysis, with no history of previous HD or transplantation, it is unlikely that RRF differed significantly in the groups. Another interesting finding was the difference in the main cause of death between groups, which helps to raise a hypothesis for the underlying mechanism behind the higher mortality in those patients with late pre-dialysis care. We observed that patients with late dialysis care died more frequently from CV disease. The absence of adequate pre-dialysis care may reflect less access to adequate implementation of CV prevention, particularly the management of traditional and (perhaps more importantly) non-traditional risk factors. In the early pre-dialysis group, the inverse predominated sepsis was compared to CV events; this perhaps justifies a greater control of risk for CV events due to early pre-dialysis care, accounting for the highest incidence for sepsis in this group.
Finally, the analysis of the dynamics of biochemical variables during the first months on PD treatment provides interesting insight about the impact of the transition between pre-dialysis to PD on the correction of the variables. In this study, while serum phosphorus levels were not significantly different between the groups divided according to pre-dialysis care during the first year of follow-up, patients with an early pre-dialysis care always presented significantly higher levels of hemoglobin and lower levels of potassium throughout the first 9 months on PD. Since these are important predictors of mortality in this population [17] , the longer exposure to inadequate control of hemoglobin and potassium may at least in part justify the higher mortality observed in the group of patients with late pre-dialysis care.
However, the observation of the independent association between late pre-dialysis care and mortality, despite being corrected for those biochemical risk factors, indicates that other factors not captured in the present analysis may be involved. Using the same rationale, since patients with late pre-dialysis care who corrected their biochemical parameters were exposed to a high risk of mortality, a memory effect of the worst control of these variables may be carried to later phases on dialysis.
This study has some limitations: first is its observational design, which demands caution when interpreting all the results; second is the lack of information regarding known risk factors for both mortality and technique failure as RRF and membrane characteristics; last, details about specific characteristics of how pre-dialysis care was delivered, and particularly the eGFR at dialysis initiation were not captured in the present study.
However, our study presents important strengths: it is based on a national prospective cohort, adjustments were performed for several covariates and the general characteristics of our population are very similar with other large cohorts from different parts of the world.
In conclusion, we showed that longer pre-dialysis care provided a significant benefit for patient survival, but did not influence the time to the first peritonitis or technique survival in this national PD cohort. The reasons for such effects should be explored in future studies.
